Search Results - "Bamba, Ryo"
-
1
The Visceral Adiposity Index Is a Predictor of Incident Chronic Kidney Disease: A Population-Based Longitudinal Study
Published in Kidney & blood pressure research (01-05-2020)“…Background and Aims: Visceral adiposity index (VAI), calculated with body mass index, high density lipoprotein-cholesterol, triglycerides and waist…”
Get full text
Journal Article -
2
Extracellular lipidome change by an SGLT2 inhibitor, luseogliflozin, contributes to prevent skeletal muscle atrophy in db/db mice
Published in Journal of cachexia, sarcopenia and muscle (01-02-2022)“…Background Diabetes mellitus increases the excretion of urinary glucose from the renal glomeruli due to elevated blood glucose levels. In the renal tubules,…”
Get full text
Journal Article -
3
Gut Microbiota Changes by an SGLT2 Inhibitor, Luseogliflozin, Alters Metabolites Compared with Those in a Low Carbohydrate Diet in db/db Mice
Published in Nutrients (27-08-2022)“…In recent years, sarcopenic obesity has been considered central pathological factors in diabetes. This study aimed to compare the effect of luseogliflozin, a…”
Get full text
Journal Article -
4
Brazilian green propolis improves gut microbiota dysbiosis and protects against sarcopenic obesity
Published in Journal of cachexia, sarcopenia and muscle (01-12-2022)“…Introduction Brazilian green propolis is an important honeybee product that is considered beneficial for health. Here, we examined the therapeutic potential of…”
Get full text
Journal Article -
5
Impact of extracellular‐to‐intracellular fluid volume ratio on albuminuria in patients with type 2 diabetes: A cross‐sectional and longitudinal cohort study
Published in Journal of diabetes investigation (01-07-2021)“…Aims/Introduction Body fluid volume imbalance is common in patients with kidney failure, and is associated with all‐cause mortality. This study aimed to…”
Get full text
Journal Article -
6
Miso, fermented soybean paste, suppresses high-fat/high-sucrose diet-induced muscle atrophy in mice
Published in Journal of Clinical Biochemistry and Nutrition (01-01-2024)“…This study investigated the effects of miso, a traditional fermented soybean food in Japan, on muscle mass atrophy. Eight week old male C57BL/6J mice were fed…”
Get full text
Journal Article -
7
801-P: SGLT2 Inhibitor, Luseogliflozin, Prevent Sarcopenia by Improving Extracellular Lipidome
Published in Diabetes (New York, N.Y.) (01-06-2021)“…Aims: It has been reported that there is a close relationship between sarcopenia obesity and metabolic disorder such as lipid metabolism. Here we investigated…”
Get full text
Journal Article -
8
1182-P: Trans Fatty Acid Intake Induces Impaired Glucose Tolerance via Dysbiosis
Published in Diabetes (New York, N.Y.) (01-06-2021)“…Trans fatty acids (TFAs) are known to increase the risk for various metabolic syndromes. The effect of TFA on dysbiosis and intestinal inflammation, especially…”
Get full text
Journal Article -
9
1943-P: The Sodium-Glucose Cotransporter 2 Inhibitor Luseogliflozin Can Suppress Muscle Atrophy in Db/Db Mice by Suppressing the Expression of Foxo1
Published in Diabetes (New York, N.Y.) (01-06-2019)“…Here we investigated the effect of the sodium glucose cotransporter-2 inhibitor (SGLT2i) luseogliflozin on skeletal muscle. Eight-week-old mice were fed a…”
Get full text
Journal Article -
10
Miso, fermented soybean paste, suppresses high-fat/high-sucrose diet-induced muscle atrophy in mice
Published in Journal of Clinical Biochemistry and Nutrition (2023)“…Dysbiosis resulting from a high fat/high sucrose diet (HFHSD) causes sarcopenia by decreasing the production of short-chain fatty acids (SCFAs). This study…”
Get full text
Journal Article